Kanji Nakatsu, Professor Emeritus of Pharmacology at Queen’s University, discusses the potential importance of stress proteins in COVID-19 and how
A group of concerned doctors and other healthcare professionals from the Okanagan region of British Columbia have written a powerful,
A new petition supporting the recognition and wide availability of Ivermectin for prophylaxis and early outpatient treatment of COVID-19 has
A practical approach to home-based care for healthy families
Evaluation of Fluvoxamine as an effective prophylactic and treatment drug for COVID-19.
Dr. David Chesler recounts the success he’s had treating nursing home patients with Ivermectin.